Good treatment outcomes depend on patient-centered pharmaceutical services that ensure that medical products are prescribed, dispensed, and used appropriately. Effective pharmaceutical services enhance patient outcomes and satisfaction by improving responsiveness to patients’ needs and contexts, reducing wastage, and maximizing efficiency. For example, with support from MSH, national stakeholders in Ethiopia successfully institutionalized clinical pharmacy services in hospitals to improve patient safety and outcomes. Pharmacists at six participating hospitals identified 79 treatment errors at the point of service between October and December 2016, all of which were immediately corrected.

Inappropriate medicine use by prescribers, nurses, pharmacists, and patients is common. Quality of pharmaceutical care is often suboptimal in low- and middle-income countries due to a lack of systems, governance, tools, standards, awareness, and expertise for providing patient-centered pharmaceutical services. Overuse and misuse of antimicrobial agents is rampant—about half of viral respiratory infections and diarrhea cases receive unneeded antibiotics. This fuels drug resistance. To be effective, pharmaceutical services need to go beyond supply management and encompass strategies and interventions to improve patient-centered care and medicine use.

MTaPS applies systems-based approaches using proven tools, interventions, and quality improvement methodologies to strengthen in-country capacity and enhance patient-centered pharmaceutical care. In doing so, MTaPS embeds the culture of quality of care emphasized by the Sustainable Development Goals, the World Health Organization, and other global and national bodies. In particular, MTaPS focuses on the following USAID results areas:

MTaPS helps countries:

With MTaPS’ help, countries will choose from and customize these strategies based on their own needs and work closely with national counterparts to achieve sustainable improvements in the use of medicines, patient-centered pharmaceutical care, and AMR containment. MTaPS helps apply such interventions in both acute and chronic care settings and for both noncommunicable and communicable diseases, including HIV and AIDS, malaria, TB, neglected tropical diseases, and mother and child health conditions.

Download MTaPS Pharmacy Services factsheet

For more information, contact:

Senior Principal Technical Advisor, Pharmaceutical Services

Mohan Joshi

mjoshi@mtapsprogram.org

Related News

Five Pharmaceutical Systems Considerations: A Crucial Link in Universal Health Coverage

Five Pharmaceutical Systems Considerations: A Crucial Link in Universal Health Coverage

December 14, 2020

Javier Guzman, ex-Technical Director, and Kwesi Eghan, Principal Technical Advisor, USAID MTaPS As w...

Read More
Containing Antimicrobial Resistance: Kenya’s Systems Approach

Containing Antimicrobial Resistance: Kenya’s Systems Approach

July 29, 2020

By Ndinda Kusu, Country Project Director, MTaPS Kenya Antimicrobial resistance (AMR) is a dire probl...

Read More
Scaling up a Digital Tool to End TB in Bangladesh

Scaling up a Digital Tool to End TB in Bangladesh

March 31, 2020

Last October, Bangladesh’s Directorate General of Health Services (DGHS) went digital—that is, i...

Read More